Results of randomised studies of the EORTC Soft Tissue and Bone Sarcoma Group (STBSG) with two different ifosfamide regimens in first- and second-line chemotherapy in advanced soft tissue sarcoma patients

A.T. van Oosterom(KU Leuven), H.T. Mouridsen(Rigshospitalet), Ole S. Nielsen(Aarhus University Hospital), P Dombernowsky(Herlev Hospital), Krzysztof Krzemieniecki(The Maria Sklodowska-Curie National Research Institute of Oncology), Ian Judson(Royal Marsden NHS Foundation Trust), L Švancárová, D. Spooner(Queen Elizabeth Hospital), C. Hermans(European Organisation for Research and Treatment of Cancer), M. van Glabbeke(European Organisation for Research and Treatment of Cancer), Jaap Verweij(Rotterdam University of Applied Sciences)
European Journal of Cancer
December 1, 2002
Cited by 164

Abstract


Related Papers

No related papers found

Powered by citation graph analysis